News

Semaglutide, a synthetic analog of glucagon-like peptide-1 (GLP-1), has garnered attention for its intriguing properties and potential implications in various r ...
Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...
Whether you’re taking Ozempic for type 2 diabetes or for weight loss, you’re probably noticing a lot of changes in your body.
Women who use an oral contraceptive might want to consider using a back-up method after starting a weight loss drug.
A study from the University of Gothenburg identifies specific brain neurons controlling semaglutide's weight loss effects.
Experts say that semaglutide and tirzepatide can help patients with heart failure lose weight, but limited NHS access is ...
Research about potential prevention strategies, including the use of semaglutide, a drug used to treat type 2 diabetes and aid weight loss, is ongoing. Results of a secondary analysis found that ...
Semaglutide use may be increasing worldwide rates of ischemic optic neuropathy and retinal adverse events, a study suggests.
Deep Apple is the latest biotech to be tapped by Novo Nordisk as the drugmaker aims to regain market share lost to Eli Lilly.
By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...
A combination treatment of semaglutide, trevogrumad and garetosmab causes fat loss and muscle growth in primate trials. Full ...